Webinar: Why Patient-Specific Insulin Dosing Matters. Watch for free today!
Case Study
Atrium Health’s Use of EndoTool IV Leads to $12 Million in Savings
Setting: Atrium Health Wake Forest Baptist, New Orleans, LA
The Customer
Atrium Health Wake Forest Baptist has successfully implemented EndoTool IV, a patient-specific insulin dosing system, to optimize the treatment of diabetic ketoacidosis (DKA), reducing hospital length of stay (LOS) and improving patient outcomes.
Challenges
Atrium Health aimed to:
- Reduce hospital LOS caused by poor glycemic control.
- Lower healthcare costs related to extended stays and hypoglycemia.
- Enhance operational efficiency in glycemic management.
Key Results
- Reduced Hospital LOS: EndoTool IV patients had a shorter average stay (3.95 days vs. 4.40 days), saving $12 million in total costs.
- Improved Patient Safety: Fewer hypoglycemic events in the EndoTool IV group (10 events of hypoglycemia vs. 350 in the standard infusion group).
- Operational Efficiency: Shorter stays allowed for better resource allocation and increased patient throughput.
“Atrium Health Wake Forest Baptist’s continued use of EndoTool IV has not only sustained improved patient outcomes but also delivered impressive cost savings. The reduction in hospital length of stay and associated cost savings underscore the enduring value of this innovative glycemic management solution.”
Joseph A. Aloi, MD
Section Chief of Endocrinology and Metabolism, Atrium Health Wake Forest Baptist
Conclusion
The use of EndoTool IV has resulted in substantial cost savings, improved patient safety, and enhanced operational efficiency, solidifying its value in clinical practice.
References
Authors
M. McKnight, C. Price, C. Usoh, G. Russell, R. Bundy, J. Aloi
Source
Evaluation of Hospital Length of Stay in Patients with DKA Treated with EndoTool. Poster presented at: American Association of Clinical Endocrinology (AACE).
Year
2024
Related posts
Case Study
Corewell Health Slashes DKA Costs by Nearly $1M in 18 Months
Corewell Health Slashes DKA Costs by Nearly $1M in 18 Months
A retrospective review evaluated DKA patients treated between January 2023 – June 2024. Outcomes were compared against Vizient’s risk-adjusted expected values and a national benchmark group of 115 academic medical centers.
Customer Stories
Why CaroMont Health Made EndoTool a Systemwide Standard for Insulin Dosing
Why CaroMont Health Made EndoTool a Systemwide Standard for Insulin Dosing
In 2009, CaroMont Health’s flagship hospital in Gaston made a forward-looking move to replace paper-based insulin protocols with EndoTool, a computerized insulin dosing system. This marked the beginning of a clinical mindset shift. From the start, the CaroMont team saw EndoTool not as a replacement for their protocols, but as a partner in better care.
Case Study
How Temple Health Reduced Hypoglycemia by Over 70% with EndoTool SubQ
How Temple Health Reduced Hypoglycemia by Over 70% with EndoTool SubQ
Following their implementation of EndoTool IV, Temple Health adopted EndoTool SubQ in 2024, a patient-specific insulin dosing system designed to provide individualized insulin recommendations based on a patient’s unique needs.
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields
